Advisory Committee Endorses Pfizer’s RSV Vaccine Candidate

An FDA advisory committee has cleared the way for Pfizer’s investigational respiratory syncytial virus (RSV) vaccine, Abrysvo (RSVpreF) — a likely blockbuster product for Pfizer if approved.
Source: Drug Industry Daily